|
ASX - By Stock
|
RNV |
Re:
Ann: Nerve Cuff approved for use in US DoD and VA hospitals
|
|
peppers01
|
68 |
9.2K |
9 |
14/11/25 |
| 14/11/25 |
ASX - By Stock
|
68
|
9.2K
|
9
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Cleansing Statement
|
|
peppers01
|
41 |
6.7K |
3 |
13/11/25 |
| 13/11/25 |
ASX - By Stock
|
41
|
6.7K
|
3
|
|
|
ASX - By Stock
|
HTG |
Re:
Ann: Harvest subscribes for notes in TRU Recognition
|
|
peppers01
|
15 |
6.6K |
0 |
11/11/25 |
| 11/11/25 |
ASX - By Stock
|
15
|
6.6K
|
0
|
|
|
ASX - By Stock
|
NYR Biotech |
Re:
NYR Valuation
|
|
peppers01
|
94 |
16K |
1 |
11/11/25 |
| 11/11/25 |
ASX - By Stock
|
94
|
16K
|
1
|
|
|
ASX - By Stock
|
NYR Biotech |
Re:
NYR Valuation
|
|
peppers01
|
94 |
16K |
7 |
11/11/25 |
| 11/11/25 |
ASX - By Stock
|
94
|
16K
|
7
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Achieves Key Clinical Milestone
|
|
peppers01
|
1.0K |
182K |
3 |
10/11/25 |
| 10/11/25 |
ASX - By Stock
|
1.0K
|
182K
|
3
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Achieves Key Clinical Milestone
|
|
peppers01
|
1.0K |
182K |
0 |
08/11/25 |
| 08/11/25 |
ASX - By Stock
|
1.0K
|
182K
|
0
|
|
|
ASX - By Stock
|
RNV |
Re:
Ann: ReNerve achieves first sales of amniotic tissue range
|
|
peppers01
|
9 |
1.1K |
3 |
07/11/25 |
| 07/11/25 |
ASX - By Stock
|
9
|
1.1K
|
3
|
|
|
ASX - By Stock
|
RNV |
Re:
Ann: ReNerve achieves first sales of amniotic tissue range
|
|
peppers01
|
9 |
1.1K |
3 |
07/11/25 |
| 07/11/25 |
ASX - By Stock
|
9
|
1.1K
|
3
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Achieves Key Clinical Milestone
|
|
peppers01
|
1.0K |
182K |
5 |
31/10/25 |
| 31/10/25 |
ASX - By Stock
|
1.0K
|
182K
|
5
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Achieves Key Clinical Milestone
|
|
peppers01
|
1.0K |
182K |
2 |
29/10/25 |
| 29/10/25 |
ASX - By Stock
|
1.0K
|
182K
|
2
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Achieves Key Clinical Milestone
|
|
peppers01
|
1.0K |
182K |
3 |
29/10/25 |
| 29/10/25 |
ASX - By Stock
|
1.0K
|
182K
|
3
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Achieves Key Clinical Milestone
|
|
peppers01
|
1.0K |
182K |
2 |
27/10/25 |
| 27/10/25 |
ASX - By Stock
|
1.0K
|
182K
|
2
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Q1 FY26 Investor Update Webinar Presentation
|
|
peppers01
|
18 |
4.7K |
9 |
20/10/25 |
| 20/10/25 |
ASX - By Stock
|
18
|
4.7K
|
9
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Change in substantial holding
|
|
peppers01
|
37 |
11K |
6 |
01/10/25 |
| 01/10/25 |
ASX - By Stock
|
37
|
11K
|
6
|
|
|
ASX - By Stock
|
BIO |
Re:
Ann: Trading Update
|
|
peppers01
|
19 |
2.6K |
6 |
01/10/25 |
| 01/10/25 |
ASX - By Stock
|
19
|
2.6K
|
6
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Achieves Key Clinical Milestone
|
|
peppers01
|
1.0K |
182K |
1 |
30/09/25 |
| 30/09/25 |
ASX - By Stock
|
1.0K
|
182K
|
1
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Achieves Key Clinical Milestone
|
|
peppers01
|
1.0K |
182K |
2 |
29/09/25 |
| 29/09/25 |
ASX - By Stock
|
1.0K
|
182K
|
2
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Achieves Key Clinical Milestone
|
|
peppers01
|
1.0K |
182K |
1 |
29/09/25 |
| 29/09/25 |
ASX - By Stock
|
1.0K
|
182K
|
1
|
|
|
ASX - By Stock
|
RNV |
Re:
Ann: ReNerve launches the EmpliQ product ranges
|
|
peppers01
|
10 |
1.3K |
4 |
22/09/25 |
| 22/09/25 |
ASX - By Stock
|
10
|
1.3K
|
4
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Xolatryp Protects Cells through Mitochondrial Stabilisation
|
|
peppers01
|
139 |
19K |
3 |
17/09/25 |
| 17/09/25 |
ASX - By Stock
|
139
|
19K
|
3
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Change in substantial holding - M Azzi
|
|
peppers01
|
16 |
2.5K |
0 |
11/09/25 |
| 11/09/25 |
ASX - By Stock
|
16
|
2.5K
|
0
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Change in substantial holding - M Azzi
|
|
peppers01
|
16 |
2.5K |
1 |
11/09/25 |
| 11/09/25 |
ASX - By Stock
|
16
|
2.5K
|
1
|
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
peppers01
|
18K |
7.0M |
12 |
10/09/25 |
| 10/09/25 |
ASX - By Stock
|
18K
|
7.0M
|
12
|
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
peppers01
|
22K |
8.2M |
6 |
10/09/25 |
| 10/09/25 |
ASX - By Stock
|
22K
|
8.2M
|
6
|
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
peppers01
|
18K |
7.0M |
5 |
05/09/25 |
| 05/09/25 |
ASX - By Stock
|
18K
|
7.0M
|
5
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYR Appoints Consultant Cardiologist for Phase IIa Trial
|
|
peppers01
|
266 |
46K |
3 |
05/09/25 |
| 05/09/25 |
ASX - By Stock
|
266
|
46K
|
3
|
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
peppers01
|
18K |
7.0M |
7 |
05/09/25 |
| 05/09/25 |
ASX - By Stock
|
18K
|
7.0M
|
7
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4E & Annual Report for the Year Ended 30 June 2025
|
|
peppers01
|
129 |
32K |
3 |
02/09/25 |
| 02/09/25 |
ASX - By Stock
|
129
|
32K
|
3
|
|
|
ASX - By Stock
|
PXX |
Re:
Ann: Trading Halt
|
|
peppers01
|
29 |
5.1K |
1 |
02/09/25 |
| 02/09/25 |
ASX - By Stock
|
29
|
5.1K
|
1
|
|
|
ASX - By Stock
|
RLG |
Re:
Ann: RLG Coffee Brand Launches in China
|
|
peppers01
|
15 |
3.2K |
1 |
02/09/25 |
| 02/09/25 |
ASX - By Stock
|
15
|
3.2K
|
1
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4E & Annual Report for the Year Ended 30 June 2025
|
|
peppers01
|
129 |
32K |
4 |
31/08/25 |
| 31/08/25 |
ASX - By Stock
|
129
|
32K
|
4
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4E & Annual Report for the Year Ended 30 June 2025
|
|
peppers01
|
129 |
32K |
6 |
29/08/25 |
| 29/08/25 |
ASX - By Stock
|
129
|
32K
|
6
|
|
|
ASX - By Stock
|
PXX |
Re:
PolarX's Alaskan copper push backed by Northern Star
|
|
peppers01
|
3 |
597 |
0 |
27/08/25 |
| 27/08/25 |
ASX - By Stock
|
3
|
597
|
0
|
|
|
ASX - By Stock
|
1AD |
Re:
Ann: TechKnow investor presentation recording
|
|
peppers01
|
2 |
679 |
2 |
22/08/25 |
| 22/08/25 |
ASX - By Stock
|
2
|
679
|
2
|
|
|
ASX - By Stock
|
RLG |
Re:
Ann: RLG Coffee Brand Launches in China
|
|
peppers01
|
15 |
3.2K |
2 |
21/08/25 |
| 21/08/25 |
ASX - By Stock
|
15
|
3.2K
|
2
|
|
|
ASX - By Stock
|
RLG |
Re:
Ann: Trading Halt
|
|
peppers01
|
15 |
5.7K |
0 |
07/08/25 |
| 07/08/25 |
ASX - By Stock
|
15
|
5.7K
|
0
|
|
|
ASX - By Stock
|
NYR |
Re:
CHART
|
|
peppers01
|
407 |
72K |
3 |
06/08/25 |
| 06/08/25 |
ASX - By Stock
|
407
|
72K
|
3
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Response to ASX Aware Letter
|
|
peppers01
|
154 |
64K |
6 |
31/07/25 |
| 31/07/25 |
ASX - By Stock
|
154
|
64K
|
6
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Webinar - Monday 28 July - Registration Information
|
|
peppers01
|
190 |
77K |
24 |
24/07/25 |
| 24/07/25 |
ASX - By Stock
|
190
|
77K
|
24
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Webinar - Monday 28 July - Registration Information
|
|
peppers01
|
190 |
77K |
8 |
24/07/25 |
| 24/07/25 |
ASX - By Stock
|
190
|
77K
|
8
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYR Advances Xolatryp Phase IIa Trial in Cardioprotection
|
|
peppers01
|
75 |
18K |
5 |
23/07/25 |
| 23/07/25 |
ASX - By Stock
|
75
|
18K
|
5
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Sofdra Launch Update Presentation - Correction
|
|
peppers01
|
226 |
88K |
30 |
23/07/25 |
| 23/07/25 |
ASX - By Stock
|
226
|
88K
|
30
|
|
|
ASX - By Stock
|
BIO |
Re:
Ann: International Market Update and New Distribution Agreements
|
|
peppers01
|
14 |
4.0K |
9 |
15/07/25 |
| 15/07/25 |
ASX - By Stock
|
14
|
4.0K
|
9
|
|
|
ASX - By Stock
|
NYR |
Re:
Accumulation by deep pockets
|
|
peppers01
|
22 |
9.0K |
1 |
11/07/25 |
| 11/07/25 |
ASX - By Stock
|
22
|
9.0K
|
1
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Provides Sofdra Launch Update
|
|
peppers01
|
1.0K |
430K |
4 |
11/07/25 |
| 11/07/25 |
ASX - By Stock
|
1.0K
|
430K
|
4
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Provides Sofdra Launch Update
|
|
peppers01
|
1.0K |
430K |
1 |
09/07/25 |
| 09/07/25 |
ASX - By Stock
|
1.0K
|
430K
|
1
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Provides Sofdra Launch Update
|
|
peppers01
|
1.0K |
430K |
1 |
09/07/25 |
| 09/07/25 |
ASX - By Stock
|
1.0K
|
430K
|
1
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Provides Sofdra Launch Update
|
|
peppers01
|
1.0K |
430K |
7 |
09/07/25 |
| 09/07/25 |
ASX - By Stock
|
1.0K
|
430K
|
7
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Provides Sofdra Launch Update
|
|
peppers01
|
1.0K |
430K |
5 |
08/07/25 |
| 08/07/25 |
ASX - By Stock
|
1.0K
|
430K
|
5
|
|